{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:37:42Z","timestamp":1774543062078,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":7,"publisher":"Springer US","isbn-type":[{"value":"9781071613535","type":"print"},{"value":"9781071613542","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1354-2_4","type":"book-chapter","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T11:04:49Z","timestamp":1614683089000},"page":"35-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit)"],"prefix":"10.1007","author":[{"given":"Sara","family":"Bravaccini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"issue":"3","key":"4_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S1525-1578(10)60625-3","volume":"2","author":"IA Sokolova","year":"2000","unstructured":"Sokolova IA, Halling KC, Jenkins RB et al (2000) The development of a multitarget multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2(3):116\u2013123","journal-title":"J Mol Diagn"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","volume":"164","author":"KC Halling","year":"2000","unstructured":"Halling KC, King W, Sokolova IA et al (2000) A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164:1768\u20131775","journal-title":"J Urol"},{"issue":"5","key":"4_CR3","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0022-5347(05)65072-0","volume":"167","author":"KC Halling","year":"2002","unstructured":"Halling KC, King W, Sokolova IA et al (2002) A comparison of BTAstat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol 167(5):2001\u20132006","journal-title":"J Urol"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/S0022-5347(05)64270-X","volume":"168","author":"MF Sarosdy","year":"2002","unstructured":"Sarosdy MF, Schellhammer P, Bokinsky G et al (2002) Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168:1950\u20131954","journal-title":"J Urol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1097\/01.ju.0000066842.45464.cc","volume":"169","author":"M Skacel","year":"2003","unstructured":"Skacel M, Fahmy M, Brainard JA et al (2003) Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169:2101\u20132105","journal-title":"J Urol"},{"issue":"10","key":"4_CR6","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1093\/annonc\/mdq740","volume":"22","author":"S Bravaccini","year":"2011","unstructured":"Bravaccini S, Casadio V, Gunelli R et al (2011) Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients. Ann Oncol 22(10):2294\u20132298","journal-title":"Ann Oncol"},{"issue":"2","key":"4_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40291-013-0023-x","volume":"17","author":"S Goodison","year":"2013","unstructured":"Goodison S, Rosser CJ, Urquidi V (2013) Bladder cancer detection and monitoring: assessment of urine-and blood-based marker tests. Mol Diagn Ther 17(2):71\u201384","journal-title":"Mol Diagn Ther"}],"container-title":["Methods in Molecular Biology","Urinary Biomarkers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1354-2_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T11:04:53Z","timestamp":1614683093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-1354-2_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071613535","9781071613542"],"references-count":7,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1354-2_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"3 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}